Synopsys/$SNPS
1D1W1MYTD1Y5YMAX
Capital at risk
About Synopsys
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
- Ticker
- $SNPS
- Sector
- Software & Cloud Services
- Primary listing
- NASDAQ
- Employees
- 28,000
- Headquarters
- Sunnyvale, United States
- Website
- www.synopsys.com
Synopsys Metrics
BasicAdvanced
$94B
86.86
$5.64
1.23
-
Price and volume
Market cap
$94B
Beta
1.23
52-week high
$539.48
52-week low
$362.55
Average daily volume
2.3M
Financial strength
Current ratio
1.337
Quick ratio
1.166
Long term debt to equity
0.311
Total debt to equity
0.348
Interest coverage (TTM)
1.66%
Profitability
EBITDA (TTM)
2,075.486
Gross margin (TTM)
82.92%
Net profit margin (TTM)
11.43%
Operating margin (TTM)
11.03%
Effective tax rate (TTM)
17.17%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
1.35%
Return on equity (TTM)
3.66%
Valuation
Price to earnings (TTM)
86.865
Price to revenue (TTM)
9.869
Price to book
3.01
Price to tangible book (TTM)
-13.15
Price to free cash flow (TTM)
33.82
Free cash flow yield (TTM)
2.96%
Free cash flow per share (TTM)
14.485
Growth
Revenue change (TTM)
46.33%
Earnings per share change (TTM)
-55.49%
3-year revenue growth (CAGR)
22.40%
10-year revenue growth (CAGR)
14.76%
3-year earnings per share growth (CAGR)
-5.35%
10-year earnings per share growth (CAGR)
13.66%
What the Analysts think about Synopsys
Analyst ratings (Buy, Hold, Sell) for Synopsys stock.
Analyst projections of the future price of Synopsys stock.
Bulls say / Bears say
Synopsys raised its 2026 revenue and profit forecasts in August as investment in AI chips and infrastructure boosted demand for its design software. This gives the company a strong near-term growth driver. (Reuters)
The Ansys combination is showing signs of operational progress: Ansys contributed $711 million in Q3, while management said cost synergies were ahead of schedule and term loans had been repaid earlier than planned. Better integration could strengthen both earnings and the combined product offering. (The Motley Fool)
At its September investor day, Synopsys forecast about 15% revenue growth in FY2027 and announced a partnership with OpenAI to develop a specialised model for chip design. If customers adopt it, the partnership could create another way to extend and monetise Synopsys’ engineering tools. (PR Newswire)
The Ansys deal left Synopsys with about $10 billion of debt, while acquired-intangible amortisation and restructuring charges have weighed on reported profit. If synergies or cash generation fall short, the debt could constrain financial flexibility. (The Motley Fool, StockTitan)
Synopsys’ FY2026 targets assume no further changes to export controls or current US Entity List restrictions. Tighter rules could limit sales to affected customers and put pressure on forecasts. (Synopsys)
AI is a source of demand today, but it could also eventually automate or bypass some commercial chip-design tools. Core EDA revenue grew 8.5% in Q3, leaving investors to watch whether AI-related demand becomes durable growth for Synopsys’ core business. (Trefis)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2026.
Synopsys Financial Performance
Revenues and expenses
Synopsys Earnings Performance
Company profitability
Upcoming events
No upcoming events
Synopsys News
AllArticlesVideos
Funds containing Synopsys
AllEURGBPUSD
Fund name | Fund size | $SNPS weighting |
|---|---|---|
VanEck Quantum Computing€QUTM | €199M | 4.89% |
Vaneck Quantum Computing£QNTG | £172M | 4.89% |
iShares MSCI USA SRI$SUAS | $3.4B | 1.08% |
iShares MSCI USA SRI€QDVR | €2.9B | 1.08% |
iShares MSCI USA SRI£SUUS | £2.5B | 1.08% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.